Patents & Publications

Patents

Papers

logo_jad
A Blood-Based, 7-Metabolite Signature for the Early Diagnosis of Alzheimer’s Disease.
Journal of Alzheimer’s Disease 2015;45(4):1157-73 See

Calero O, García-Albert L, Rodríguez-Martín A, Veiga S, Calero M. A fast and cost-effective method for apolipoprotein E isotyping as an alternative to APOE genotyping for patient screening and stratification. Sci Rep. 2018 Apr 13;8(1):5969. doi: 10.1038/s41598-018-24320-3. See

Sergio Veiga, Andrés Rodríguez-Martín, Guillermo Garcia-Ribas, Ignacio Arribas, Miriam Menacho-Román, Miguel Calero. Validation of a novel and accurate ApoE4 assay for automated chemistry analyzers. Sci Rep. 2020 Feb. doi: 10.1038/s41598-020-58841-7. See

Publications

Veiga S et al. 2018. Amyolid proteins: Methods and protocols. 3rd ed (Chapter 28) Springer Science. See

Posters

A Blood-Based 7-Metabolite Signature for the Early Diagnosis of Alzheimer’s Disease. CTAD 2014 (Philadelphia, PE)

A new cost-effective method for quantification of total ApoE in human plasma samples. AAIC 2017 (London)

APOE ε4 stratification of Alzheimer’s disease patients defines two distinct set of plasma metabolic markers related to lipid or mitocondrial metabolism dysfunction. AAIC 2016 (Toronto)

ApoE 4 blood marker assay. A NEW NON-GENETIC METHOD TO EVALUATE ALZHEIMER´S DISEASE RISK
USING CLINICAL CHEMISTRY PLATFORMS. CTAD 2016 (San Diego, CA)

If you have any questions or comments, we will be pleased to attend you

CONTACT US

Avda. Francisco Vallés, 8
47151 Boecillo (Valladolid) - Spain

+34 983 54 98 96

About us Products Investor & press Contact

About us Products
Investor & press Contact

Legal Advice / Disclaimer / Cookie Policy / Privacy policy